Clinical investigation: head and neck
Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin e1 analog misoprostol (RTOG 96-07)11Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.